BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37534091)

  • 1. GPRC5A regulates proliferation and oxidative stress by inhibiting the STAT3/Socs3/c-MYC pathway in hepatocellular carcinoma.
    Zhang L; Yang W; Yang J; Sun F
    J Clin Biochem Nutr; 2023 Jul; 73(1):43-51. PubMed ID: 37534091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gprc5a deletion enhances the transformed phenotype in normal and malignant lung epithelial cells by eliciting persistent Stat3 signaling induced by autocrine leukemia inhibitory factor.
    Chen Y; Deng J; Fujimoto J; Kadara H; Men T; Lotan D; Lotan R
    Cancer Res; 2010 Nov; 70(21):8917-26. PubMed ID: 20959490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of suppressors of cytokine signaling 3 promotes aggressiveness in hepatocellular carcinoma.
    Wu WY; Kim H; Zhang CL; Meng XL; Wu ZS
    J Invest Surg; 2014 Aug; 27(4):197-204. PubMed ID: 24476004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo and in vitro effects of microRNA-221 on hepatocellular carcinoma development and progression through the JAK-STAT3 signaling pathway by targeting SOCS3.
    Huang S; Zhou D; Li YX; Ming ZY; Li KZ; Wu GB; Chen C; Zhao YN
    J Cell Physiol; 2019 Apr; 234(4):3500-3514. PubMed ID: 30370582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repression of GPRC5A is associated with activated STAT3, which contributes to tumor progression of head and neck squamous cell carcinoma.
    Liu S; Ye D; Wang T; Guo W; Song H; Liao Y; Xu D; Zhu H; Zhang Z; Deng J
    Cancer Cell Int; 2017; 17():34. PubMed ID: 28270740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GPRC5A promotes gallbladder cancer metastasis by upregulating TNS4 via the JAK2-STAT3 pathway.
    Yang J; Li X; Chen S; Li G; Pu P; Yang Y; Wu W; Geng Y; Liu Y
    Cancer Lett; 2024 Jun; ():217067. PubMed ID: 38942137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and prognostic value of HER-2/neu, STAT3 and SOCS3 in hepatocellular carcinoma.
    Jiang LH; Hao YL; Zhu JW
    Clin Res Hepatol Gastroenterol; 2019 Jun; 43(3):282-291. PubMed ID: 30385249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
    Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
    Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C1QTNF1-AS1 regulates the occurrence and development of hepatocellular carcinoma by regulating miR-221-3p/SOCS3.
    Li H; Zhang B; Ding M; Lu S; Zhou H; Sun D; Wu G; Gan X
    Hepatol Int; 2019 May; 13(3):277-292. PubMed ID: 31069760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung Tumor Suppressor GPRC5A Binds EGFR and Restrains Its Effector Signaling.
    Zhong S; Yin H; Liao Y; Yao F; Li Q; Zhang J; Jiao H; Zhao Y; Xu D; Liu S; Song H; Gao Y; Liu J; Ma L; Pang Z; Yang R; Ding C; Sun B; Lin X; Ye X; Guo W; Han B; Zhou BP; Chin YE; Deng J
    Cancer Res; 2015 May; 75(9):1801-14. PubMed ID: 25744720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of protein disulfide‑isomerase A3 expression inhibits cell proliferation and induces apoptosis through STAT3 signaling in hepatocellular carcinoma.
    Kondo R; Ishino K; Wada R; Takata H; Peng WX; Kudo M; Kure S; Kaneya Y; Taniai N; Yoshida H; Naito Z
    Int J Oncol; 2019 Apr; 54(4):1409-1421. PubMed ID: 30720090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ZnAs@SiO
    Huang Y; Zhou B; Luo H; Mao J; Huang Y; Zhang K; Mei C; Yan Y; Jin H; Gao J; Su Z; Pang P; Li D; Shan H
    Theranostics; 2019; 9(15):4391-4408. PubMed ID: 31285768
    [No Abstract]   [Full Text] [Related]  

  • 13. MEX3C-Mediated Decay of SOCS3 mRNA Promotes JAK2/STAT3 Signaling to Facilitate Metastasis in Hepatocellular Carcinoma.
    Xiao Y; Li Y; Shi D; Wang X; Dai S; Yang M; Kong L; Chen B; Huang X; Lin C; Liao W; Xu B; Chen X; Wang L; Chen X; Ouyang Y; Liu G; Li H; Song L
    Cancer Res; 2022 Nov; 82(22):4191-4205. PubMed ID: 36112698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FXR induces SOCS3 and suppresses hepatocellular carcinoma.
    Guo F; Xu Z; Zhang Y; Jiang P; Huang G; Chen S; Lyu X; Zheng P; Zhao X; Zeng Y; Wang S; He F
    Oncotarget; 2015 Oct; 6(33):34606-16. PubMed ID: 26416445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevation of GPRC5A expression in colorectal cancer promotes tumor progression through VNN-1 induced oxidative stress.
    Zhang L; Li L; Gao G; Wei G; Zheng Y; Wang C; Gao N; Zhao Y; Deng J; Chen H; Sun J; Li D; Zhang X; Liu M
    Int J Cancer; 2017 Jun; 140(12):2734-2747. PubMed ID: 28316092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CircSOD2 induced epigenetic alteration drives hepatocellular carcinoma progression through activating JAK2/STAT3 signaling pathway.
    Zhao Z; Song J; Tang B; Fang S; Zhang D; Zheng L; Wu F; Gao Y; Chen C; Hu X; Weng Q; Yang Y; Tu J; Ji J
    J Exp Clin Cancer Res; 2020 Nov; 39(1):259. PubMed ID: 33234142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compound Kushen Injection intervenes metabolic reprogramming and epithelial-mesenchymal transition of HCC via regulating β-catenin/c-Myc signaling.
    Wang KX; Du GH; Qin XM; Gao L
    Phytomedicine; 2021 Dec; 93():153781. PubMed ID: 34649212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anisodamine Suppressed the Growth of Hepatocellular Carcinoma Cells, Induced Apoptosis and Regulated the Levels of Inflammatory Factors by Inhibiting NLRP3 Inflammasome Activation.
    Li P; Liu Y; He Q
    Drug Des Devel Ther; 2020; 14():1609-1620. PubMed ID: 32425506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long Noncoding RNA HOST2 Promotes Epithelial-Mesenchymal Transition, Proliferation, Invasion and Migration of Hepatocellular Carcinoma Cells by Activating the JAK2-STAT3 Signaling Pathway.
    Wu Y; Yuan T; Wang WW; Ge PL; Gao ZQ; Zhang G; Tang Z; Dang XW; Zhao YF; Zhang JY; Jiang GZ
    Cell Physiol Biochem; 2018; 51(1):301-314. PubMed ID: 30453302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A traditional prescription comprising Astragali Radix and Schisandra chinensis Fructus induces apoptosis and protective autophagy in hepatocellular carcinoma cells.
    Zhu PL; Li JK; Jiang XL; Zhang SQ; Zhang Z; Wang Y; Zhang Z; Chen WQ; Yung KK
    J Ethnopharmacol; 2023 Aug; 312():116548. PubMed ID: 37100264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.